Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Roberto BianchiGuido Cavaletti

Abstract

Antineoplastic drugs, such as cisplatin (CDDP), are severely neurotoxic, causing disabling peripheral neuropathies with clinical signs known as chemotherapy-induced peripheral neurotoxicity. Cotreatment with neuroprotective agents and CDDP has been proposed for preventing or reversing the neuropathy. Erythropoietin given systemically has a wide range of neuroprotective actions in animal models of central and peripheral nervous system damage. However, the erythropoietic action is a potential cause of side effects if erythropoietin is used for neuroprotection. We have successfully identified derivatives of erythropoietin, including carbamylated erythropoietin, which do not raise the hematocrit but retain the neuroprotective action exerted by erythropoietin. We have developed previously an experimental chemotherapy-induced peripheral neurotoxicity that closely resembles CDDP neurotoxicity in humans. The present study compared the effects of erythropoietin and carbamylated erythropoietin (50 microg/kg/d thrice weekly) on CDDP (2 mg/kg/d i.p. twice weekly for 4 weeks) neurotoxicity in vivo. CDDP given to Wistar rats significantly lowered their growth rate (P < 0.05), with slower sensory nerve conduction velocity (P < 0.001) and redu...Continue Reading

References

Jan 1, 1992·Annals of Neurology·S C ApfelJ A Kessler
Jan 1, 1991·Annals of Neurology·S C ApfelJ A Kessler
Mar 29, 1990·Biochimica Et Biophysica Acta·R SatakeK Asano
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S CascinuG Catalano
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·G CavalettiG Tredici
Apr 3, 1998·Journal of Neuro-oncology·G TrediciG Cavaletti
Nov 12, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·G LauriaD R Cornblath
Dec 29, 1998·Archives of Neurology·J C McArthurJ W Griffin
Oct 3, 1999·Experimental Neurology·G TrediciG Cavaletti
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P G RoseR McGehee
Feb 25, 2000·Blood Purification·K C Mun, T A Golper
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrinesA Cerami
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·F T RuschitzkaM Gassmann
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·A L SirénP Ghezzi
Aug 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W M Campana, R R Myers
Apr 17, 2002·Journal of Neurology·Stefan Quasthoff, Hans Peter Hartung
Dec 20, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thomas QuaschningMax Gassmann
Mar 18, 2003·Journal of Neuropathology and Experimental Neurology·M BuemiN Frisina
May 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Serhat ErbayraktarMichael Brines
Sep 27, 2003·The European Journal of Neuroscience·W Marie Campana, Robert R Myers
Jan 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Roberto BianchiPietro Ghezzi
Feb 6, 2004·Brain : a Journal of Neurology·Min Sheng WangJonathan D Glass
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Murat DigicayliogluStuart A Lipton
Aug 10, 2004·Medical Oncology·Bulent OrhanSevda Muftuoglu
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerP Soubeyran
Oct 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael BrinesAnthony Cerami
Oct 8, 2004·Annals of Neurology·Sanjay C KeswaniAhmet Hoke
Oct 27, 2004·Expert Opinion on Drug Safety·Guido Cavaletti, Paola Marmiroli
Feb 5, 2005·European Heart Journal·Andrea NataliEle Ferrannini

❮ Previous
Next ❯

Citations

Mar 28, 2008·Current Neurology and Neuroscience Reports·Bushra Malik, Mark Stillman
Sep 18, 2008·Current Pain and Headache Reports·Bushra Malik, Mark Stillman
Dec 31, 2010·Current Treatment Options in Neurology·Guido CavalettiEmanuela Susani
Jul 27, 2010·Neuroscience Bulletin·Min-Suk YoonGerald Holtmann
Oct 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Nicolas AuthierAlain Eschalier
Mar 21, 2007·Expert Reviews in Molecular Medicine·James R Goss
Oct 5, 2007·Nature Clinical Practice. Neurology·Giuseppe Lauria, Grazia Devigili
Jun 2, 2007·BMJ : British Medical Journal·Giuseppe Lauria, Raffaella Lombardi
Jan 14, 2009·Molecular Cancer Therapeutics·Sarah R McWhinneyHoward L McLeod
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew H MillerMichael R Irwin
Nov 11, 2010·Pakistan Journal of Biological Sciences : PJBS·Lobna Abdelaal Kassem, Nadia Aziz Yassin
Apr 16, 2014·Vascular Pharmacology·Minmin ZhuChanghong Miao
Mar 3, 2010·Expert Opinion on Therapeutic Patents·Francis Dumont, Pierre Bischoff
Feb 22, 2014·Expert Opinion on Investigational Drugs·Monique van VelzenMichael Brines
Jul 12, 2008·Expert Opinion on Investigational Drugs·Paul A Lapchak
Dec 21, 2010·Muscle & Nerve·Melissa P Wu, Emanuela Gussoni
May 31, 2011·Best Practice & Research. Clinical Anaesthesiology·Derya SarginHannelore Ehrenreich
Sep 7, 2007·Neurobiology of Disease·Kelli A SullivanEva L Feldman
Jun 22, 2007·Lancet Neurology·Claudia Sommer, Giuseppe Lauria
Jan 26, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roberto BianchiGuido Cavaletti
Nov 7, 2006·Cancer Treatment Reviews·Cara A Rabik, M Eileen Dolan
Apr 25, 2009·British Journal of Haematology·Francesca Merchionne, Franco Dammacco
Dec 19, 2007·Chemical Biology & Drug Design·David R KhanGregg B Fields
May 17, 2007·European Journal of Immunology·Pietro Ghezzi, Manuela Mengozzi
Mar 8, 2008·British Journal of Haematology·Murat O Arcasoy
Jul 22, 2008·Histopathology·G LauriaG Devigili
Mar 19, 2008·Journal of the Peripheral Nervous System : JPNS·Anthony J Windebank, Wolfgang Grisold
Aug 20, 2010·Journal of Neuroscience Research·Daniele MaggioniGiovanni Tredici
Apr 27, 2010·Biochemical Pharmacology·Edna Cukierman, David R Khan
Mar 12, 2015·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Nivin SharawyMagdy Fouad Youakim
Jun 7, 2016·Journal of Pharmacological and Toxicological Methods·Simon AuthierMichael J Curtis
Dec 21, 2013·The Journal of Clinical Investigation·Deirdre R PachmanLauren E Ta
Feb 3, 2018·Journal of Clinical Medicine·Daniela Ostrowski, Ralf Heinrich
Feb 11, 2016·Biochemistry Insights·Jianmin ChenXiao Zhang
Sep 18, 2007·Journal of Glaucoma·James C TsaiMax Forbes
Mar 15, 2015·The Oncologist·Abolfazl AvanGodefridus J Peters
Aug 5, 2011·Clinical Pharmacology and Therapeutics·D R PachmanC L Loprinzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Journal of the Peripheral Nervous System : JPNS
Giuseppe LauriaGuido Cavaletti
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Roberto BianchiGuido Cavaletti
© 2022 Meta ULC. All rights reserved